Noura S. Hanafy

New quinazoline sulfonamide derivatives as potential anticancer agents: Identifying a promising hit with dual EGFR/VEGFR-2 inhibitory and radiosensitizing activity

Mostafa M. Ghorab, Aiten M. Soliman, Khaled El‐Adl et al. · Bioorganic Chemistry · 2023 · 36 citations

Medicinal Chemistry, Medicine, Pharmacology +9

Five and six membered heterocyclic rings endowed with azobenzene as dual EGFR^T790M and VEGFR-2 inhibitors: design, synthesis, <i>in silico</i> ADMET profile, molecular docking, dynamic simulation and anticancer evaluations

Kurls E. Anwer, Sanadelaslam S. A. El‐Hddad, Nour E. A. Abd El‐Sattar et al. · RSC Advances · 2023 · 34 citations · Full text

Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment

Noura S. Hanafy, Nada A. A. M. Aziz, Sanadelaslam S. A. El‐Hddad et al. · Archiv der Pharmazie · 2023 · 22 citations · Full text

Design and synthesis of some barbituric and 1,3-dimethylbarbituric acid derivatives: A non-classical scaffold for potential PARP1 inhibitors

Essam Eldin A. Osman, Noura S. Hanafy, Riham F. George et al. · Bioorganic Chemistry · 2020 · 19 citations

Combinatorial Chemistry, Medicinal Chemistry, Pharmaceutical Science +12

Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations

Abeer A. Mohamed, Sanadelaslam S. A. El‐Hddad, Ahmed K. B. Aljohani et al. · Bioorganic Chemistry · 2023 · 17 citations

Molecular Docking, Medicinal Chemistry, Egfrt790m Dual Inhibitors +12